Alexandria Real Estate Equities-backed gene-edited seed developer Cibus has withdrawn its IPO application three months after setting a price range that would have raised $107m at the upper end.
Cibus, a US-based plant-breeding technology developer backed by life sciences real estate manager Alexandra Real Estate Equities, has withdrawn its proposed initial public offering.
The company did not offer a reason for its decision. It filed for an offering on the Nasdaq Global Select Market in November 2018 and planned to issue approximately 6.67 million shares priced at $14 to $16, according to a securities filing in February 2019.
Founded in 2001, Cibus has developed a gene-editing platform…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
